Impact of Exoskeleton Use on Perceived Effort and Pain During Resident Handling in Nursing Home Care Staff
Exo 2
Impact of Daily Exoskeleton Use (HAPO Version 4) on Perceived Exertion and Musculoskeletal Health in Nursing Home Care Staff Performing Resident Handling in Decubitus: A Prospective Multicenter Observational Study (EXO 2)
1 other identifier
observational
35
1 country
5
Brief Summary
The EXO 2 study assessed whether daily use of an exoskeleton - a wearable mechanical support device - could reduce physical effort and pain in nursing home care staff who regularly perform resident handling tasks such as bed baths and diaper changes. Care staff in nursing homes (EHPADs) are among the most affected workers by musculoskeletal disorders (MSDs), which are the leading cause of occupational illness and sick leave in the French healthcare sector. Handling of residents in lying positions (decubitus), such as turning, washing, or changing residents in bed, is one of the most physically demanding tasks and a major source of lower and upper back strain. The HAPO Version 4 exoskeleton is a wearable device worn around the torso that provides mechanical support to the upper body and back during forward-bending tasks. This study is part of a research program that progressively evaluated and improved the HAPO exoskeleton through four earlier phases with LNA Santé care staff. The main questions this study aimed to answer were: Does wearing the HAPO exoskeleton daily reduce the perceived effort (physical fatigue) felt in the upper body during resident handling? Does the exoskeleton reduce upper body pain (neck, shoulders, arms, back, hips) over time? How well do care staff integrate the exoskeleton into their daily work routine? Does exoskeleton use reduce workplace accidents and sick leave related to handling? What participants did: First 2 weeks (baseline): worked normally without the exoskeleton, completing a daily logbook to record pain and workload Following 11 weeks (intervention): wore the exoskeleton daily during all bed baths and resident changes in decubitus, continuing the daily logbook Completed weekly assessments of perceived effort and satisfaction with the device Were assessed at the end of the study (Day 91) with a final evaluation The study took place across 5 LNA Santé nursing homes in France and included 35 volunteer care staff members.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 31, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 11, 2026
August 1, 2026
5 months
July 31, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Upper Body Perceived Exertion During Resident Handling as Assessed by the Borg CR10 Scale at Day 28, Day 35, Day 63, and Day 91
The Borg CR10 (Category Ratio 10) is a validated ratio scale measuring subjective perceived exertion during physical tasks. In this study, it is applied to upper body effort (neck, shoulders, upper arms, back, hips/waist) experienced during resident handling in decubitus position. Completed weekly by participants. Score ranges from 0 (nothing at all) to 10 (maximal exertion); higher score = greater perceived effort. Baseline is the mean of scores at Day 7 and Day 14 (pre-exoskeleton phase). Change from baseline = weekly score minus mean baseline score.
Baseline (Day 7 and Day 14, without exoskeleton) and weekly from Day 15 to Day 91; key analysis time points: Day 28, Day 35, Day 63, and Day 91
Secondary Outcomes (9)
Change from Baseline in Daily Upper Body Pain Intensity as Assessed by the Visual Analog Scale (VAS) at Day 21, Day 28, Day 70, and Day 91
Daily from Day 0 to Day 91; key analysis time points: Day 21, Day 28, Day 70, and Day 91
Rate of Exoskeleton Use (Full, Partial, or Refused) During the Intervention Period
Daily from Day 15 to Day 91
Change in Participant Satisfaction with the HAPO V4 Exoskeleton Over the Intervention Period
Weekly from Day 15 to Day 91
Evolution of Weekly Number of Resident Handling Tasks in Decubitus During the Study Period
Weekly from Day 7 to Day 91
Change in Restricted Absenteeism Rate in Participating Units Before, During, and After the Exoskeleton Intervention
Retrospective data from Month -12 to Month -1 and prospective data from Month 1 to Month 6, collected at end of study
- +4 more secondary outcomes
Study Arms (1)
Care Staff Exoskeleton Cohort
Volunteer nursing home care staff (nursing assistants, registered nurses, personal care assistants) from 5 LNA Santé EHPADs, who regularly perform resident handling tasks in decubitus position (bed baths, diaper changes), enrolled during a 2-week baseline phase without exoskeleton followed by 11 weeks of daily HAPO V4 exoskeleton use. The cohort includes both asymptomatic staff (primary prevention) and staff with prior upper body pain history (secondary prevention)
Interventions
The HAPO Version 4 is a passive (non-motorized), CE-marked, wearable exoskeleton worn around the torso, designed to provide mechanical support to the dorsal and lumbar spine during forward-bending tasks. It is individually fitted to each participant's morphology. Care staff wore the device daily during all bed baths and diaper changes performed with residents in decubitus position, throughout their working shifts (day and night), from Day 15 to Day 91 (11 weeks). Usage was voluntary on a daily basis. Exoskeleton use did not replace existing patient-handling equipment. The device was supplied and maintained by Ergo Santé (France
Eligibility Criteria
Volunteer care staff (nursing assistants, registered nurses, personal care assistants, psychomotor therapists) from five LNA Santé nursing homes in France who regularly perform resident handling tasks in decubitus position.
You may qualify if:
- Currently employed at the study site for at least 1 month, with a completed probationary period
- Working in an open care unit (unité ouverte) of a LNA Santé nursing home (EHPAD), either day or night shifts
- Regularly performing care tasks for residents in lying position (decubitus), including bed baths and diaper changes
- Able to read and write French
- Having provided written informed consent to participate in the study
You may not qualify if:
- Pre-existing diagnosed back condition or rheumatological disease (such as rheumatoid arthritis or polymyalgia rheumatica) or shoulder condition (shoulder prosthesis or rotator cuff tear) that would prevent safe exoskeleton use
- Any other health condition preventing exoskeleton wear
- Employment contract shorter than the study duration
- Unable to give written informed consent
- Person protected under French law (pregnant, breastfeeding or recently delivered woman; minor; person under legal protection; person deprived of liberty - as per Articles L1121-5 to L1121-8 of the French Public Health Code)
- Not affiliated with a French social security scheme
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- LNA SANTElead
Study Sites (5)
Villa Océane
Belz, 56550, France
Résidence Marconi
Chatou, 78400, France
Les Jardins d'Olonne
Les Sables-d'Olonne, 85100, France
Résidence Creisker
Pornichet, 44380, France
Les Jardins de Leysotte
Villenave-d'Ornon, 33140, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Romain OLIVIER
ergo.creisker@lna-sante.com
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2026
First Posted
August 11, 2026
Study Start
January 23, 2025
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
August 11, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. Results of this study will be disseminated through publication in a peer-reviewed scientific journal. Data are governed by the French CNIL Reference Methodology MR-004, which precludes sharing of pseudonymized individual-level data outside the study framework. The small sample size (35 participants across 5 sites) also presents a re-identification risk that precludes IPD sharing. Aggregated, anonymized results and the study protocol will be available upon publication.